Our Mission:
To develop and provide quantitative tools and services to enhance decision making in diagnosis, prognosis, and treatment of cardiac patients.
To develop and provide quantitative tools and services to enhance decision making in diagnosis, prognosis, and treatment of cardiac patients.
|
At a Glance
 Whether you are a patient, clinician in private practice, researcher, or a drug development organization, our suite of software solutions and services can speed and substantiate diagnosis, improve your workflow, help you monitor therapies for better prognosis, enhance outcomes from both a clinical, business and legal perspective, and put you at the leading edge of innovation. Diagnosoft® is the company distinguished for developing HARP®, the first FDA 510k-cleared software designed for the analysis and quantification of tagged magnetic resonance images. We offer you powerful tools for measuring and visualizing cardiac muscle strain, motion, and performance, often called regional cardiac function, at a level not possible until now. We also provide other cardiac MRI quantification tools for measuring mass, volume, EF and flow. |
© 2009 Diagnosoft. All rights reserved